financetom
Business
financetom
/
Business
/
Reborn Coffee Acquires 58% Stake in South Korean Bakery Chain
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Reborn Coffee Acquires 58% Stake in South Korean Bakery Chain
Nov 9, 2024 11:19 AM

09:58 AM EST, 11/06/2024 (MT Newswires) -- Reborn Coffee ( REBN ) said Wednesday it has acquired a 58% stake in South Korean chain Bbang Ssaem Bakery.

Financial terms were not disclosed.

The acquisition, which follows a recent memorandum of understanding between the two companies, will provide a base to enter South Korea's franchise sector, Reborn Coffee ( REBN ) said.

Bbang Ssaem Bakery has 31 locations across South Korea and had trailing twelve months revenue of about $7 million through November, the company said.

Reborn Coffee ( REBN ) shares were up 2.4% in recent trading.

Price: 1.73, Change: +0.01, Percent Change: +0.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
RumbleOn Appoints Michael Quartieri CEO, Cameron Tkach COO
RumbleOn Appoints Michael Quartieri CEO, Cameron Tkach COO
Jan 14, 2025
04:01 AM EST, 01/14/2025 (MT Newswires) -- RumbleOn ( RMBL ) said late Monday it has appointed Michael Quartieri chief executive officer. Quartieri serves as the chairman of the company's board and succeeds CEO Michael Kennedy. The company also promoted Cameron Tkach, vice president of dealership operations, to chief operating officer. The leadership changes became effective on Monday. ...
Hutchmed Says Orpathys Receives Full Approval in China
Hutchmed Says Orpathys Receives Full Approval in China
Jan 14, 2025
04:20 AM EST, 01/14/2025 (MT Newswires) -- Hutchmed ( HCM ) said late Monday that China's National Medical Products Administration has approved its supplemental new drug application for Orpathys to treat certain adult patients with non-small cell lung cancer. The drugmaker said the regulator also converted Orpathys' prior conditional approval for previously treated patients to full approval. The updated label...
Vaxart Says Oral Covid-19 Vaccine Candidate Recommended for Continued Study
Vaxart Says Oral Covid-19 Vaccine Candidate Recommended for Continued Study
Jan 14, 2025
04:09 AM EST, 01/14/2025 (MT Newswires) -- Vaxart ( VXRT ) said late Monday an independent data safety monitoring board has recommended that a phase 2b trial of its oral Covid-19 vaccine candidate continue without any modifications. The company said the US Food and Drug Administration is reviewing the safety data from the study. Upon favorable review, the company will...
BurTech Acquisition, Blaize Complete Business Combination
BurTech Acquisition, Blaize Complete Business Combination
Jan 14, 2025
03:52 AM EST, 01/14/2025 (MT Newswires) -- BurTech Acquisition ( BRKH ) and Blaize said late Monday they have completed their business combination and formed a new entity called Blaize Holdings. The companies said the combined entity will begin trading on Nasdaq under the ticker symbols BZAI and BZAIW starting Tuesday. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved